Skip To Content

Study ID: Alliance A011203

Title:

A Randomized Phase II Trial of Tamoxifen versus Z-Endoxifen in Postmenopausal Women with Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer

Location:
Bemidji Clinic, Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Miroslaw Mazurczak, MD,Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Breast - Invasive
Stage:
Phase II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.